Atlas Trials

Radium-223 in Biochemically Recurrent Prostate Cancer

Clinical trial NCT04206319 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT04206319
Sponsor
National Cancer Institute (NCI)
Status
ACTIVE_NOT_RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Biochemical Recurrent Prostate Cancer
Start date
2020-09-22
Primary completion
2026-02-10
Enrollment
19

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.